Publisher: Icon Group International, Inc.
Category: Prescription Drugs

Prescription Drugs market research reports by Icon Group International, Inc.

(297 reports matching your criteria)
    • The 2025-2030 World Outlook for Analgesics

      The 2025-2030 World Outlook for Analgesics This study covers the world outlook for analgesics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the per ... Read More

    • The 2025-2030 World Outlook for Medical Morphine

      The 2025-2030 World Outlook for Medical Morphine This study covers the world outlook for medical morphine across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More

    • The 2025-2030 World Outlook for Hereditary Angioedema

      The 2025-2030 World Outlook for Hereditary Angioedema This study covers the world outlook for hereditary angioedema across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More

    • The 2025-2030 World Outlook for Non-Infectious Macular Edema Treatments

      The 2025-2030 World Outlook for Non-Infectious Macular Edema Treatments This study covers the world outlook for non-infectious macular Edema treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the ... Read More

    • The 2025-2030 World Outlook for Stress Management Treatments

      The 2025-2030 World Outlook for Stress Management Treatments This study covers the world outlook for stress management treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More

    • The 2025-2030 World Outlook for Anxiety Disorder Therapeutics

      The 2025-2030 World Outlook for Anxiety Disorder Therapeutics This study covers the world outlook for anxiety disorder therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More

    • The 2025-2030 World Outlook for Weight Control Products

      The 2025-2030 World Outlook for Weight Control Products This study covers the world outlook for weight control products across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More

    • The 2025-2030 World Outlook for Deficit Hyperactivity Disorder Drugs

      The 2025-2030 World Outlook for Deficit Hyperactivity Disorder Drugs This study covers the world outlook for deficit hyperactivity disorder drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the countr ... Read More

    • The 2025-2030 World Outlook for Phenylketonuria Treatments

      The 2025-2030 World Outlook for Phenylketonuria Treatments This study covers the world outlook for phenylketonuria treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More

    • The 2025-2030 World Outlook for Lipid Disorder Treatments

      The 2025-2030 World Outlook for Lipid Disorder Treatments This study covers the world outlook for lipid disorder treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More

    • The 2025-2030 World Outlook for Macular Degeneration Treatments

      The 2025-2030 World Outlook for Macular Degeneration Treatments This study covers the world outlook for macular degeneration treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More

    • The 2025-2030 World Outlook for Nephropathic Cystinosis Treatments

      The 2025-2030 World Outlook for Nephropathic Cystinosis Treatments This study covers the world outlook for nephropathic cystinosis treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in ... Read More

    • The 2025-2030 World Outlook for Neurodegenerative Diseases Treatments

      The 2025-2030 World Outlook for Neurodegenerative Diseases Treatments This study covers the world outlook for neurodegenerative diseases treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the coun ... Read More

    • The 2025-2030 World Outlook for Tamiflu (Oseltamivir Phosphate)

      The 2025-2030 World Outlook for Tamiflu (Oseltamivir Phosphate) This study covers the world outlook for tamiflu (oseltamivir phosphate) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More

    • The 2025-2030 World Outlook for Idiopathic Inflammatory Myopathy Treatments

      The 2025-2030 World Outlook for Idiopathic Inflammatory Myopathy Treatments This study covers the world outlook for idiopathic inflammatory myopathy treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ... Read More

    • The 2025-2030 World Outlook for Neuroendocrine Tumor Treatments

      The 2025-2030 World Outlook for Neuroendocrine Tumor Treatments This study covers the world outlook for neuroendocrine tumor treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More

    • The 2025-2030 World Outlook for Allergy Drugs

      The 2025-2030 World Outlook for Allergy Drugs This study covers the world outlook for allergy drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), t ... Read More

    • The 2025-2030 World Outlook for Hepatitis C Drugs

      The 2025-2030 World Outlook for Hepatitis C Drugs This study covers the world outlook for hepatitis c drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More

    • The 2025-2030 World Outlook for Cardiovascular Drugs

      The 2025-2030 World Outlook for Cardiovascular Drugs This study covers the world outlook for cardiovascular drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More

    • The 2025-2030 World Outlook for Pain Management Drugs and Devices

      The 2025-2030 World Outlook for Pain Management Drugs and Devices This study covers the world outlook for pain management drugs and devices across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More

    • The 2025-2030 World Outlook for Urinary Incontinence and Overactive Bladder

      The 2025-2030 World Outlook for Urinary Incontinence and Overactive Bladder This study covers the world outlook for urinary incontinence and overactive bladder across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ... Read More

    • The 2025-2030 World Outlook for Erectile Dysfunction Drugs

      The 2025-2030 World Outlook for Erectile Dysfunction Drugs This study covers the world outlook for erectile dysfunction drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More

    • The 2025-2030 World Outlook for Vasculitis Treatments

      The 2025-2030 World Outlook for Vasculitis Treatments This study covers the world outlook for vasculitis treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More

    • The 2025-2030 World Outlook for Critical Limb Ischemia Treatments

      The 2025-2030 World Outlook for Critical Limb Ischemia Treatments This study covers the world outlook for critical limb ischemia treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More

    • The 2025-2030 World Outlook for Bronchitis Treatments

      The 2025-2030 World Outlook for Bronchitis Treatments This study covers the world outlook for bronchitis treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More

4 5 6 7 8 9 10 11 12

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings